Previous Article | Next Article 
Journal of Virology, October 2001, p. 9799-9807, Vol. 75, No. 20
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.20.9799-9807.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Overexpression of Simian Virus 40 Small-T Antigen
Blocks Centrosome Function and Mitotic Progression in Human
Fibroblasts
Stéphanie
Gaillard,
Kelly M.
Fahrbach,
Rajini
Parkati,
and
Kathleen
Rundell*
Department of Microbiology-Immunology and the
Robert H. Lurie Comprehensive Cancer Center, Northwestern
University, Chicago, Illinois
Received 5 February 2001/Accepted 25 July 2001
 |
ABSTRACT |
Recombinant adenoviruses that express high levels of the simian
virus 40 (SV40) small-t (ST) antigen have been used to study the
requirement for ST to drive cell cycle proliferation of confluent human
diploid fibroblasts. This occurs when either large-T (LT) antigen or
serum is added to provide a second signal. While cells readily
completed S phase in these experiments, they were found to accumulate
with 4N DNA content. Cellular and nuclear morphology, as well as the
biochemical status of cyclin B complexes, showed that these cells
entered mitosis but were blocked prior to mitotic metaphase. The defect
appears to reflect an inability of cells overexpressing ST to form
organized centrosomes that duplicate and separate normally during the
cell cycle and, therefore, the absence of a mitotic spindle. The
ability of ST to bind protein phosphatase 2A was required for this
pattern, suggesting that altered phosphorylation of key centrosomal
components may occur when ST is overexpressed. Although the possible
significance of ST effects on the centrosome cycle is not fully
understood, these findings suggest that ST could influence chromosomal
instability patterns that are a hallmark of SV40-transformed cells and
LT expression.
 |
INTRODUCTION |
The early region of simian virus 40 (SV40) encodes three proteins that can be detected in nonpermissive,
transforming infections (44, 50). The best understood of
these is the large-T (LT) antigen, which binds tumor suppressor
proteins p53 and pRb and has DNA binding, helicase, and transactivation
capabilities (reviewed in references 12, 22, and 32). An
amino-terminal dnaJ domain is also required for viral DNA replication
and transformation (40, 49). In LT, the dnaJ domain
modulates the protein stability of p130 and p107, members of the pRb
family. (41). A key function of the small-t (ST) antigen
is its binding to protein phosphatase 2A (PP2A). ST mimics cellular
regulatory B subunits (28, 29, 48) of this trimeric enzyme
and, presumably, modifies the substrate specificity and intracellular
localization of PP2A (36, 39). ST expression in primary
cells results in activation of key cellular kinases and growth
regulators, such as mitogen-activated protein kinase, its kinase
MEK, and the ion transporter, the Na-H antiporter (19,
38). These enzymes are all more highly phosphorylated in the
presence of ST, consistent with an inhibition of phosphatase activity
against these target molecules.
ST enhances the efficiency of virus transformation and tumor formation
in animal model systems. A role for ST in hamsters (2) or
transgenic mice is particularly apparent in nondividing tissues
(5), consistent with the general concept that ST enhances cell cycle progression. Considerable evidence to support this concept
came from early tissue culture studies (18, 23), one of
which showed that a few rounds of cell division could bypass the ST
requirement in a hamster cell system (23).
ST is not required for the transformation of all cell types in
cultures. However, whenever ST is required, its ability to interact
with PP2A has proven to be essential for transformation (25,
33). Human diploid fibroblasts (HDFs) are particularly dependent
upon ST in SV40-mediated transformation (3, 7, 33).
Neither focus formation nor anchorage-independent growth occurred when
human cells were transfected with constructs that express LT but no ST.
When both ST and LT were introduced, transformation resulted with good efficiency.
One of the earliest steps leading to cell transformation by SV40 is the
induction of cell cycle progression. When defective recombinant
adenoviruses (Ads) that independently express LT or ST were used to
study cell cycle reentry of confluent, density-arrested HDFs, neither
LT nor ST expression alone was sufficient to drive confluent HDFs back
into the cell cycle. Coinfection with Ad-LT and Ad-ST, however, allowed
the majority of the culture to progress through G1 and S
phases of the cell cycle (34). The joint requirement for
these SV40 proteins reflected the ability of LT to decrease levels of
the cyclin kinase inhibitor p21 in HDFs, while ST expression led to
decreased levels of p27. Interestingly, fresh serum addition also
decreased p21 levels, leading to the prediction that Ad-ST-infected cells would induce cell cycle progression in the presence of fresh serum, a prediction that was confirmed experimentally.
In the course of studies with Ad-ST, there appeared to be a block in
the progression of cells through G2/M, despite efficient cell cycle reentry. The present report extends studies of the cell
cycle in this system, with particular emphasis on the failure of cells
to complete mitosis. This correlated with an altered centrosome cycle
as a consequence of the inhibition of PP2A by ST.
 |
MATERIALS AND METHODS |
Cell culture, synchronization, and infection.
HDFs were
isolated from infant foreskins and grown for not more than nine
passages at a split ratio of 1:10. Ad-EIA/B-transformed human embyronic
kidney (293) cells were used to grow recombinant Ads. All
cells were maintained in Dulbecco's modified Eagle medium (DME)
containing 10% fetal calf serum (FCS), penicillin-streptomycin, and
L-glutamine at 37°C in 6% CO2.
The construction of the recombinant Ads has been previously described
(33). The viruses express wild-type (WT) ST (Ad-ST) or
mutant forms of ST. One virus, Ad-43/45, expresses ST with a double
mutation (P43L K45N) in the dnaJ domain. A second recombinant virus,
Ad-103, expresses ST with a mutant PP2A interaction domain (C103S).
Ad-CMV is a control virus which contains the cytomegalovirus (CMV) immediate-early promoter found in all other constructs but no ST coding sequences.
HDFs arrest naturally at confluence with a
G
0/G
1 2N DNA content. Cell cycle analysis by
flow cytometry (see below) showed
that >90% of the cells had a 2N DNA
content. Subconfluent HDFs
were arrested by two methods. First, cells
were plated in the
presence of 2.5 mM hydroxyurea (HU; Sigma) and then
infected.
HU was added to noninfected cells at the time of plating and
again
at the end of the 1-h infection period. Cells were released from
the HU block by being washed twice with phosphate-buffered saline
(PBS)
and addition of fresh DME and FCS to the cells. Such cells
entered S
phase almost immediately. In a few experiments, subconfluent
HDFs were
arrested in G
1 by incubation for 36 to 48 h in DME
containing
0.5% FCS. Following readdition of serum, such cells reached
S
phase after about 16 to 20 h. As for confluent cultures, cells
arrested either by HU or by low serum showed predominantly a 2N
DNA
content.
Cell cycle analysis by flow cytometry.
Analysis of HDFs by
flow cytometry was described previously (34). Briefly,
nuclei were prepared from trypsinized cells using Triton X-100 and
stained with propidium iodide in the presence of RNase before analysis
on a Becton Dickinson flow cytometer using Cell-Quest software.
Detection of BrdU incorporation.
Subconfluent HDFs on
coverslips were transfected with 2 µg of a plasmid expressing ST
antigen plus 0.5 µg of a plasmid expressing green fluorescent protein
(GFP) using Lipofectamine. The plasmids used were derivatives of pCMVt,
a plasmid that encodes a cDNA version of ST under the control of the
CMV promoter. On the morning after transfection, residual reagents were
removed by aspiration of the transfection medium and fresh medium
containing 0.5% FCS was added to the cells. Two days later (3 days
posttransfection), bromodeoxyuridine (BrdU) was added, the mixture was
incubated for 8 h, and then cells were fixed in 10% formaldehyde
to preserve GFP staining and permeabilized by washing in PBS containing
0.5% NP-40. Fixed cells were treated for 20 min with 2 N HCl to
denature double-stranded DNA, thus exposing BrdU residues for antibody recognition. The timing of this step was quite critical because prolonged exposure to acid eliminated the GFP signal. Nuclei containing incorporated BrdU were detected by using antibodies to BrdU
(Boehringer) and rhodamine-conjugated secondary antibodies.
Western blotting.
Cells were washed twice with ice-cold PBS
and scraped in a 1-ml volume of PBS. Cells were pelleted by
centrifugation at 5,000 rpm in a Beckman J2-HS centrifuge for 5 min at 4°C. The supernatant was removed, and the cells were lysed
with cold lysis buffer (50 mM Tris [pH 7.4], 200 mM NaCl, 1 mM EDTA,
1 mM EGTA, 1 mM dithiothreitol, 2% glycerol, 0.5% NP-40) supplemented
with protease and phosphatase inhibitors (0.5 mM phenylmethylsulfonyl
fluoride, 10 µg each of leupeptin, pepstatin, and aprotinin per ml; 1 mM NaF, and 1 mM sodium orthovanadate). Extracts were incubated on ice
for 15 min with periodic vigorous vortexing. Insoluble material was
then removed by centrifugation at 14,000 rpm in a Beckman J2-HS
centrifuge for 10 min at 4°C and transfer of the supernatant to a
clean microcentrifuge tube. Total protein concentrations were
determined by using the Bio-Rad Protein Assay system with bovine serum
albumin as the calibration standard. Equal amounts of total protein
were resolved by sodium dodecyl sulfate-12% polyacrylamide gel
electrophoresis and transferred to Immobilon membranes (Millipore). For
cyclin B Western assays, the membranes were incubated with anti-cyclin B primary antibody (1:1,000 in PBS-0.1% Tween 20-5% milk;
Santa Cruz Biotechnology), followed by a horseradish
peroxidase-conjugated secondary antibody. Monoclonal antibody PAB419
(17) was used at a dilution of 1:50 for detection of ST
antigen. Proteins were visualized with enhanced-chemiluminescence
reagents (Pierce Chemical).
Cyclin B immunoprecipitation kinase assays.
Cells were
extracted in cold lysis buffer as described above. Equal amounts of
protein (typically, 50 to 100 µg) were used in all experiments and
were incubated with 1 µg of anti-cyclin B antibody. Extracts and
antibody were incubated for 2 h at 4°C. Immunoprecipitates were
collected by using protein A-agarose beads (Santa Cruz Biotechnology).
The beads were washed three times in lysis buffer and twice in kinase
buffer (50 mM HEPES [pH 7.4], 10 mM MgCl2, 1 mM
MnCl2, 1 mM dithiothreitol). Immunoprecipitates were
resuspended in 40 µl of kinase buffer containing 25 µg of histone
H1 (Gibco BRL) per ml and 15 µCi of [
-32P]ATP (3,000 mCi/mmol; Amersham) and then incubated at 37°C for 30 min. Reactions
were stopped by the addition of sodium dodecyl sulfate sample buffer
and then boiled for 5 min.
Immunofluorescence microscopy.
For visualization of mitotic
antigens by the antimitotic protein monoclonal 2 antibody (MPM-2;
Upstate Biotechnology Inc.) and DNA by 4',6'-diamidino-2-phenylindole
(DAPI; Sigma) staining, cells grown on coverslips were fixed at room
temperature for 20 min with 3.7% formaldehyde in PBS containing
Ca2+ and Mg2+ and permeabilized for 5 min with
0.3% NP-40 in PBS. For MPM-2 staining, fixed cells were incubated with
MPM-2 antibody (1:100 in PBS) for 1 h at 37°C, washed
extensively, and then incubated with a fluorescein-conjugated secondary
antibody (4 µg/ml, 37°C for 1 h). To detect chromosomal DNA
morphology, DAPI was used at a concentration of 2 µg/ml. For
-tubulin staining, formalin-fixed cells on coverslips were
permeabilized for 6 min in cold methanol and then first incubated with
mouse anti-
-tubulin (Sigma; 1:8,000 in PBS containing 25% FCS).
Centrin was visualized by using monoclonal antibody 20H5, a kind gift
of Jeffrey Salisbury (Mayo Clinic, Rochester, Minn.) (30,
35). For anticentrin antibody staining, cells were fixed and
permeabilized in cold methanol-acetone (1:1) at
20°C for 10 min and
the primary antibody was used at a dilution of 1:500 in PBS containing
25% fetal bovine serum. Secondary anti-mouse antibody for both
anti-
-tubulin and anti-centrin staining was fluorescein tagged and
was used at 1:1,000 (PBS containing 40% fetal bovine serum). All
stained coverslips were mounted onto slides by using Gelvatol
(Sigma) containing 1,4-diazabicyclo[2,2,2]octane (0.1 mg/ml; Sigma).
 |
RESULTS |
Cell cycle induction by Ad-ST and serum requires the PP2A binding
function.
Previous studies showed that confluent
(density-arrested) HDFs require two signals to reenter the cell cycle,
one provided by SV40 LT or fresh serum and the other provided by ST.
Cell cycle induction in this system depends on the ability of ST
antigen to bind and inhibit PP2A. This was shown by using Ad-103, a
recombinant virus that encodes the C103S mutant form of ST (Fig.
1). Cells infected with this mutant form
of Ad-ST did not show significant S or G2/M populations,
even in the presence of 10% serum. In contrast, a virus that expressed
mutant ST with an altered dnaJ domain (Ad-43/45) was able to drive cell
cycle progression in the presence of serum. Although not shown here,
comparable levels of ST protein were found in cells infected with the
various Ads if the multiplicity of Ad-103 was increased two- to
threefold. However, no significant cell cycling was found, even with
multiplicities as high as 50 PFU/cell. In contrast, even 5 PFU of WT
Ad-ST per cell led to cell cycle reentry.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 1.
Cell cycle induction by Ad-ST in the presence of serum.
Confluent HDFs were mock infected or infected at 20 PFU/cell with Ad-ST
or the mutant Ad-43/45 or Ad-103. In profiles labeled + Serum,
cells were incubated after infection in DME containing 10% FCS. For
the Ad-ST control (upper right panel), cells were incubated in DME
containing only 0.5% FCS after infection. At 32 h postinfection,
cells were trypsinized and processed for flow cytometry.
|
|
Cell cycle progression of transfected HDF.
Ad-ST experiments
have the advantage that the entire population of cells can be infected,
making it possible to detect alterations in levels of proteins such as
the cyclin kinase inhibitors p21 and p27. However, the levels of ST
expressed by the recombinant viruses are very high, beyond even those
expressed by cells that are productively infected with SV40. To examine
ST effects on cell cycle progression in a different system, we turned
to transfections of subconfluent HDFs. When cells are mock transfected
and then placed in low concentrations of serum the next day, they
become increasingly quiescent over the next 2 days. By 60 to 72 h
posttransfection, there is little ongoing cell cycling, as measured by
BrdU incorporation (Fig. 2). In contrast,
25 to 30% of cells transfected with plasmids that express ST continue
to incorporate BrdU under these conditions, indicative of continued S
phase progression. As for the Ad-ST experiments, the PP2A-binding
mutant form of ST (mutant 103) was particularly defective in allowing
continued DNA synthesis. In contrast to experiments with recombinant
Ads, the dnaJ mutant (mutant 43/45) also had a greatly reduced ability
to support cell cycling in transfection experiments. This suggests that
the dnaJ domain of ST may contribute to the stimulation of cell growth but that the need for this domain may be overcome when high levels of
ST are expressed in cells. Interestingly, cotransfections with the 103 and 43/45 mutant plasmids showed at least partial complementation between these two mutant forms of ST antigen.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 2.
BrdU incorporation (S phase progression) by transfected
cells. HDFs plated on coverslips (30 to 40% confluent) were
transfected with 0.5 µg of pEGFP and 2 µg of a pCMVt-derived
construct that expressed WT ST, the P43L K45N mutant (column 43), C103S
(column 103), or a mixture of the two mutant constructs (column
43+103). These plasmids all encode cDNA versions of ST. The DL control
plasmid is not a cDNA but carries a deletion of the ST splice donor and
makes no ST protein or truncated fragment. On the day after infection,
the medium was changed to DME-0.5% serum. At 48 h later, BrdU
was added, the mixture was incubated for 8 h, and then coverslips
were fixed for immunofluorescence assay using anti-BrdU antibodies and
a rhodamine-tagged secondary antibody. Data are expressed as the
percentage of GFP-positive cells showing positive anti-BrdU staining.
|
|
Overexpression of ST affects G2/M progression.
During the course of the Ad-ST experiments described above, we noticed
an accumulation of cells in G2/M in the
fluorescence-activated cell sorter (FACS) profiles (Fig. 1; note the
Ad-ST plus serum panel, in particular). As shown in Fig.
3, Ad-ST-infected cells showed
significant G2/M accumulation by 1 day postinfection,
reaching a maximum of 40% of the cells in G2/M. The
accumulation in G2/M persisted for even as long as 52 h postinfection, when only a small fraction of the cells appeared to
reenter G1, reducing the G2/M peak. There was
no evidence in these experiments of a cycling tetraploid population,
which would have been evident if peaks with greater DNA contents had
appeared at later times.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 3.
Kinetics of cell cycle induction by ST in the presence
of serum. Confluent HDFs were infected with Ad-ST at 20 PFU/cell, and
then medium containing 10% serum was added back at the end of the
infection period. Cells were collected and processed for flow cytometry
at 18, 25, 32, 42, and 52 h postinfection (hpi).
|
|
The expression of cyclin B is necessary as cells transit G
2
and enter mitosis (
20). To determine whether ST was
affecting
the expression of cyclin B and therefore inhibiting the
progression
of the cells through G
2, Western blot analyses
were performed
to ascertain the cyclin B protein levels in cells
induced by ST
plus serum. As shown in Fig.
4A, cells infected with Ad-ST in
the
presence of serum showed an increase in the amount of cyclin
B
expressed by 24 h postinfection and levels increased further
by
32 h postinfection. High levels of cyclin B persisted for at
least
another day, additional evidence that cells cannot complete
mitosis
where cyclin B destruction occurs normally in the cell
cycle
(
20).

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 4.
Cyclin B and cyclin B-associated kinase levels of
arrested cells. (A) Confluent HDFs were infected with Ad-ST at 20 PFU/cell and then maintained in 10% FCS after infection. Extracts were
prepared at 24, 32, 42, and 52 h postinfection, and levels of
cyclin B were compared to those found in controls (Ad-ST alone, FCS
alone) by Western blot analysis. (B) The same extracts were used for
immunoprecipitation-kinase assays in which histone H1 was the substrate
for cyclin B1-associated kinase activity.
|
|
Accumulated cyclin B is typical of both G
2 and M phases of
the cell cycle. Activation of the cyclin B-dependent kinase cdc2
does
not occur in G
2 but is typical of the prophase stage of
mitosis.
To measure cdc2 activity, cyclin B-cdc2 complexes were
immunoprecipitated
by using an anti-cyclin B monoclonal antibody and
then assaying
immune complexes for the ability to phosphorylate H1
histone in
the presence of [

-
32P]ATP. Cells infected
with Ad-ST in the presence of serum showed
high levels of cyclin B
kinase, which persisted for more than
20 h with only a slight
decline (Fig.
4B). These data suggest
that the cells have indeed
entered mitosis and are either unable
to degrade their cyclin B, which
is required for exit from mitosis,
or have not reached anaphase, the
stage at which cyclin B would
normally be
degraded.
Immunohistochemistry provided additional evidence that Ad-ST-infected
cells actually enter mitosis. Cells were stained with
antibodies to
MPM-2, a phosphorylated epitope shared by a set
of proteins
phosphorylated at the onset of mitosis (
6,
9).
As seen in
Fig.
5B, many cells in Ad-ST-infected
cultures (right
panel) showed increased MPM-2 staining. These cells
were rounder
and showed stain in both their nuclear and cytoplasmic
portions.
This staining pattern would be expected for normal cells
because
the initiation of mitosis is associated with the breakdown of
the nuclear envelope. In addition, dense, dark areas in the nuclear
areas of cells stained with anti-MPM2 antibody appeared like a
ring of
condensed chromosomes. This suggested that cells had undergone
chromosome condensation and entered mitosis. Cells stained with
DAPI
(Fig.
5A) confirmed the presence of condensed chromosomes
that were not
aligned on a metaphase plate. Thus, these cells
have a prometaphase
profile in which cells have undergone chromosome
condensation and
breakdown of the nuclear membrane and have high
levels of cyclin B-cdc2
kinase activity.

View larger version (59K):
[in this window]
[in a new window]
|
FIG. 5.
MDM-2 staining and chromosomal morphology in arrested
cells. HDFs were plated on coverslips and then infected with Ad-ST in
the presence of 10% serum. At 32 h postinfection, cells were
fixed with formalin and permeabilized with NP-40 as described in
Materials and Methods. The cells in panels A were stained with DAPI,
and those in panels B were stained with anti-MPM-2 antibody.
Ad-ST-infected cells are shown on the right side of both sets, while
control Ad-CMV-infected cells are on the left.
|
|
An analysis of the mitotic profiles of cells in one experiment is shown
in Table
1. In this experiment, 63% of
the cells
had 4N DNA content and about half of these appeared to be in
prophase
(condensed chromatin not aligned on a metaphase plate). None
of
the cells showed metaphase or anaphase chromosomal patterns,
suggesting
that one block to cell cycle progression occurred in the
progression
to or through metaphase. Interestingly, this analysis also
revealed
an earlier premitotic block that had not been appreciated
previously.
Only half of the cells with 4N DNA content were actually in
prophase,
suggesting that the other half of these cells remained
blocked
in G
2 and never entered mitosis. It is possible
that confluent
cells that overcome a G
1 arrest now
encounter a G
2 checkpoint.
ST may allow some, but not all,
cells to bypass this checkpoint
but then blocks their progression
through M.
PP2A binding is necessary for prometaphase block.
The dnaJ
domain of ST was not required for the premetaphase block to cell cycle
progression, because cells infected with Ad-43/45 showed the same MPM2
and DAPI staining patterns described above (data not shown). To analyze
the role of the PP2A-binding domain, it was necessary to drive cell
cycle progression in an ST-independent fashion, because cells infected
with Ad-103 do not enter G1/S and progress to
G2/M (Fig. 1). In contrast to confluent HDFs which cannot
reenter the cell cycle in response to serum stimulation, serum-deprived
subconfluent HDFs can proliferate in response to freshly added serum.
Thus, HDFs were plated and grown to one-third confluence, deprived of
serum to synchronize the cells in G0/G1, and
then infected with Ad-ST and serum stimulated. As shown in Fig.
6, a majority of the cells infected with
Ad-ST became blocked in G2/M and remained in this stage of
the cell cycle for over 50 h. In contrast, cells infected with
Ad-103 reached G2/M but failed to remain in mitosis and
reentered G1 within 8 h. DAPI staining confirmed that
Ad-103-infected cells decondensed their DNA and resumed interphase
appearance at this time (data not shown). It is also worth noting that
the experiments with the 103 mutant and similar experiments with Ad-LT
(not shown) showed that the mitotic arrest was not an artifact related
to Ad infection. Rather, mitotic arrest required ST antigen,
specifically, its PP2A inhibition function. This suggests that
sequestering of PP2A by ST may prevent critical dephosphorylation
reactions required for the progression of mitosis.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 6.
The C103S mutation alters G2/M arrest
patterns. Subconfluent cells were kept in DME-0.5% FCS for 38 h
and then infected with Ad-ST (WT or C103S) at 20 PFU/cell. Medium
containing 10% FCS was added after infection to allow the cells to
reenter the cell cycle. Cells were collected at 24, 32, and 50 h
postinfection (hpi) and processed for flow cytometry.
|
|
PP2A inhibition inhibits centrosome maturation and
duplication.
The prometaphase appearance of nuclei from
Ad-ST-infected cells suggested that cells were unable to assemble a
mitotic spindle. Indeed, staining of arrested cells with
-tubulin
(data not shown) provided no evidence for a mitotic spindle, in
agreement with the nonaligned appearance of the condensed chromosomes.
A key component of the spindle apparatus is the centrosome, so we
looked for centrosomal structures by staining for the
centrosome-associated tubulin
-tubulin. Centrosomes mature and
thicken during G1 and S phases of the cell cycle, forming
structures that are clearly detectable by
-tubulin staining
(27). In late S or early G2, centrosomes
duplicate and then begin to move away from one another toward the poles
of the cell. To determine how the normal centrosome cycle was affected
in Ad-ST-infected cells, we compared the
-tubulin staining patterns
of uninfected and Ad-ST-infected subconfluent cells at defined times in
the cell cycle. Cells were first plated in the presence of HU to arrest
them at the G1/S border before infection. This procedure
was used rather than serum deprivation because, following release of
the HU block, cells transit S and proceed toward M in a more rapid and
synchronized fashion. On the day after plating in HU, cells were
infected with Ads and then kept in HU for 8 h to allow ST
expression. Cells were then washed to remove HU and allowed to proceed
through S and into G2. Centrosome patterns were studied at
various times after release of the HU block. Figure
7A shows an example of the staining
patterns of cells 10 h after the release of the HU block, and the
data shown in Table 2 summarize the
patterns from viewing many fields of cells. The 10-h time point was
chosen because this was when the maximum numbers of duplicated and
separated centrosomes were found in control cell populations. As shown
in Table 2, centrosomes were clearly visible in nearly all
Ad-CMV-infected cells, with 18% showing clearly separated centrosomes
that were at or moving toward the poles of the cells. In contrast, none
of the Ad-ST-infected cells showed duplicated centrosomes and only a
few had distinct single centrosomes. The vast majority showed diffuse,
disorganized staining with anti-
-tubulin, suggesting that
centrosomal maturation had not occurred and thickened centrosomes of
detectable size and structure were not present in these cells. These
findings suggest that the failure of ST-expressing cells to transit
mitosis reflected the inability of their centrosomes to undergo a
normal cycle to produce a normal spindle apparatus.

View larger version (88K):
[in this window]
[in a new window]
|
FIG. 7.
Anti- -tubulin and anticentrin immunofluorescence.
HDFs were plated on coverslips in the presence of HU for 24 h and
then mock infected or infected with Ad-ST at 20 PFU/cell for 8 h.
Cell cycle progression was then initiated by washing out the HU and
adding DME-10% FCS. At various times after HU release, cells were
fixed and permeabilized and then stained for -tubulin. The cells
shown were stained with anti- -tubulin (A) 10 h after HU release
or with anticentrin antibody (B) 15 h after HU washout. Cells
infected with Ad-ST are shown on the right side of each panel, and
control Ad-CMV-infected cells are on the left.
|
|
Another indication that centrosomes were aberrant came from staining
with an anticentrin antibody. Centrin is a structural
component of the
centrosome body but is also found in centrosome-free
pools within the
cell (
30). As cells approached mitosis 15 h
after
release of the HU block, centrin was particularly enriched
in the
nuclei of Ad-CMV-infected cells (Fig.
7B). In contrast,
centrin
staining was much weaker in Ad-ST-infected cells and was
not localized
to the nuclear compartment. The disorganized, weak
centrin staining in
these cells further suggests a defect in normal
centrosome dynamics
when ST is overexpressed in
HDFs.
 |
DISCUSSION |
During studies of the role of ST antigen in promoting cell cycle
progression, a pronounced block to G2/M progression was
noted in experiments using recombinant Ads which overexpress ST
antigen. This was first apparent by an accumulation of cells with 4N
DNA content in FACS analyses. Such cells showed the increased levels of
cyclin B1 that would be expected in either G2 or early M,
but the presence of active cyclin B-associated cdc2 activity suggested that at least some cells had moved into early mitosis. This was confirmed by immunofluorescence for the MPM-2 mitotic epitope (6,
9). In nonmitotic cells, MPM-2 staining is faint and localized
to the nucleus. When cells enter mitosis, fluorescence intensity
increases and staining is found throughout the cell because the
integrity of the nuclear envelope is altered in mitotic cells. Of the
cells infected with Ad-ST in the presence of serum, 30 to 50% showed
this early mitotic staining pattern. DAPI staining showed that a
similar fraction of cells contained highly condensed chromosomes that
were not aligned in a metaphase arrangement. This pattern was observed
for about half of the cells with 4N DNA content. The remaining half
were arrested at an earlier point, in G2 but before M.
The interference with mitosis described here almost certainly reflects
the overexpression of ST that occurs with the Ad vectors, but this
finding raises the possibility that ST transiently interferes with
mitotic progression, a possibility discussed later in greater detail.
It is not surprising that low levels of ST do not cause the severe
phenotypes found in the Ad-ST-infected cells because a complete block
to mitotic completion would be incompatible with cell survival.
Interestingly, a lethal mutation with phenotypes similar to those
reported here was described in drosophila (37). In this
case, P element insertion into the PP2A catalytic subunit inactivated
its function. Homozygous mutant embryos totally deficient in PP2A
showed overcondensed chromatin and an arrest between prophase and
anaphase (37) at a stage in development where rapid
mitotic cycles are required. Our studies of Ad-ST-infected cells
confirm in a completely different system that PP2A activity is required for the assembly of a functional mitotic spindle and suggest that PP2A
inhibition blocks an early step in centrosome assembly and maturation.
Consistent with the behavior of the drosophila mutant, mitotic arrest
by ST depends on its binding to PP2A. This function of ST maps to its
C-terminal half, in particular, to a CXXXPXC motif found at
residues 97 to 103 (25). Studies with the C103S mutant
indicated that it is the PP2A interaction function that accounts for
the cell cycle arrest described in Ad-ST-infected HDFs. In contrast,
mutation of the dnaJ domain of ST, a region involved in STs
transactivation function, had no effect on the ability of ST to drive
cell cycle progression and mitotic arrest (25).
A well-defined mitotic checkpoint responds to damage to the mitotic
spindle. Proteins such as BUB1 and MAD1 (21) or the polo-like kinases are critical in the metaphase-anaphase transition and
may well be sensitive to the state of PP2A in cells (8, 16). In yeast, there is strong genetic evidence that a specific PP2A B subunit is required for the spindle checkpoint response (47). However, there is a key difference here. Cells
arrested by ST expression never form a mitotic spindle, so the block to mitotic progression occurs before this checkpoint is believed to function.
The absence of identifiable centrosomes in Ad-ST-infected cells
suggests that arrest occurs not through activation of a checkpoint but
because the spindle cannot form. The centrosome cycle is coupled to the
cell cycle. However, the failure of Ad-ST-infected cells to assemble
centrosomes does not correlate with an obvious difficulty in cell cycle
transit because these cells clearly reach G2/M and many
enter early mitosis. In addition, ST is known to promote cell cycle
progression and to relieve p27-mediated inhibition of cell cycle
kinases (34). One might expect that reduced p27 levels
would result in overly active cyclin E-cdk2 and that this would lead to
excessive centrosome amplification (10, 51). In contrast,
the inability to detect any centrosomes in Ad-ST-infected cells
suggests that an even earlier step in centrosome maturation or
assembly, one that precedes centrosome duplication, is blocked.
It is possible that interference with some upstream activity indirectly
affects the centrosome cycle, although this would have to be a function
that is nonessential for cell cycle progression. Alternatively,
inhibition of PP2A may directly alter a key centrosomal component
(14), many of which are known to be regulated by
phosphorylation. An interesting example is NPM/B23 (26), a
protein associated with unduplicated centrosomes that dissociates from
them after phosphorylation with cyclin E-2 cdk2. Other molecules are
C-Nap1 (24), a protein that mediates centriole-centriole
adhesion, and Nek2, a protein which influences centrosomal separation
(15, 45). Some preliminary experiments have been performed
for centrosomal proteins for which good reagents are available. While
no differences in the kinetics or accumulation of Nek2 were found
(unpublished observations), the reduced centrin staining found in
Ad-ST-infected cells (Fig. 7B) lends further support to the idea that
centrosomal components are directly affected. The expression and
phosphorylation status of key centrosomal proteins like these should
provide greater insights into whether effects of ST on the centrosome
cycle are likely to be direct or indirect.
Finally, although the severe defects found in Ad-ST infections could
not persist if cells were to survive, the possibility of transient
interference with normal centrosome function evokes an interesting
speculation on its possible contribution to chromosomal instability.
This phenotype has been described for several tumor cell lines and
results from a failure of the mitotic spindle checkpoint (1). When mitotic progression is blocked by drugs like
colchinine and vinblastine, some tumor lines fail to arrest but rather
decondense their chromosomes and reenter the cell cycle, leading to
increased ploidy and subsequent chromosomal rearrangement. Defects in
p53 activity, among other things, can contribute to bypass of mitotic arrest. In SV40 infections, in which LT binds and inhibits p53 activity, a transient delay to mitotic progression caused by altered activity of centrosomal proteins could lead to a similar scenario. It
is very unlikely that the pronounced arrest described here ever occurs
in a natural infection, where levels of viral proteins may be
high immediately after infection but fall shortly thereafter. Lower levels are also present in stably transformed cells lines. However, even a temporary delay in the progression of cells
through mitosis could promote aberrant cell cycle reentry and
chromosomal decondensation.
There is increasing evidence that tumor viruses can interfere with
normal mitotic progression, leading to altered ploidy and genetic
instability. LT and the papillomavirus E6 protein serve as prototypes
for proteins that alter p53-sensitive checkpoints (4, 31, 42, 43,
46), and mechanisms that influence the centrosome cycle have
also been recently described in papillomavirus systems
(11). LT expression leads to tetraploidization of
permissive monkey cells (13) through unknown mechanisms.
It will be interesting to formally test whether ST contributes to
LT-driven genetic instability in systems where levels and duration of
expression of the viral proteins can be limited and controlled.
 |
ACKNOWLEDGMENTS |
This work was supported by Public Health Service grant CA-21327
(K.R.). We acknowledge the support of the Lester Woods Foundation, through the Robert H. Lurie Comprehensive Cancer Center, in providing some of the equipment used in this study.
We appreciate the technical assistance of Marlena Wilson. We thank
Jeffrey Salisbury (Mayo Clinic, Rochester, Minn.) for the kind gift of
the anticentrin monoclonal antibody.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology-Immunology, Searle Research Bldg., Mail code S213,
Northwestern University, 320 E. Superior St., Chicago, IL 60611-3010. Phone: (312) 503-5917. Fax: (312) 503-1339. E-mail:
krundell{at}northwestern.edu.
Present address: Duke University Medical School, Durham, NC 27701.
Present address: Chicago Medical School, North Chicago, IL 60064.
 |
REFERENCES |
| 1.
|
Cahill, D. P.,
C. Lengauer,
J. Yu,
G. J. Riggins,
J. K. Willson,
S. D. Markowitz,
K. W. Kinzler, and B. Vogelstein.
1998.
Mutations of mitotic checkpoint genes in human cancers.
Nature
392:300-303[CrossRef][Medline].
|
| 2.
|
Carbone, M.,
A. M. Lewis,
B. J. Matthews,
A. S. Levine, and K. Dixon.
1989.
Characterization of hamster tumors induced by simian virus 40 small t deletion mutants as true histiocytic lymphomas.
Cancer Res.
49:1565-1571[Abstract/Free Full Text].
|
| 3.
|
Chang, L.-S.,
M. Pater,
N. Hutchinson, and G. di Mayorca.
1984.
Tranformation by purified early genes of simian virus 40.
Virology
133:341-353[CrossRef][Medline].
|
| 4.
|
Chang, T. H.,
F. A. Ray,
D. A. Thompson, and R. Schlegel.
1997.
Disregulation of mitotic checkpoints and regulatory proteins following acute expression of SV40 large T antigen in diploid human cells.
Oncogene
14:2383-2393[CrossRef][Medline].
|
| 5.
|
Choi, Y.,
I. Lee, and S. R. Ross.
1988.
Requirement for the simian virus 40 small t antigen in tumorigenesis in transgenic mice.
Mol. Cell. Biol.
8:3382-3390[Abstract/Free Full Text].
|
| 6.
|
Davis, F. M.,
T. Y. Tsao,
S. K. Fowler, and P. N. Rao.
1983.
Monoclonal antibodies to mitotic cells Proc.
Natl. Acad. Sci. USA
80:2926-2930[Abstract/Free Full Text].
|
| 7.
|
De Ronde, A.,
C. J. A. Sol,
A. van Strien,
J. ter Schegget, and J. van der Noordaa.
1989.
The SV40 small t antigen is essential for the morphological transformation of human fibroblasts.
Virology
171:260-263[CrossRef][Medline].
|
| 8.
|
Descombes, P., and E. A. Nigg.
1998.
The polo-like kinase Plx1 is required for M phase exit and destruction of mitotic regulators in Xenopus egg extracts.
EMBO J.
17:1328-1335[CrossRef][Medline].
|
| 9.
|
Ding, M.,
Y. Feng, and D. D. Vandre.
1997.
Partial characterization of the MPM-2 phosphoepitope.
Exp. Cell Res.
231:3-13[CrossRef][Medline].
|
| 10.
|
Doxsey, S. J.
1998.
The centrosome a tiny organelle with big potential.
Nat. Genet.
20:104-106[CrossRef][Medline].
|
| 11.
|
Duensing, S.,
L. Y. Lee,
A. Duensing,
J. Basile,
S. Piboonniyom,
S. Gonzalez,
C. P. Crum, and K. Munger.
2000.
The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle.
Proc. Natl. Acad. Sci. USA
97:10002-10007[Abstract/Free Full Text].
|
| 12.
|
Fanning, E.
1992.
Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture.
J. Virol.
66:1289-1293[Free Full Text].
|
| 13.
|
Friedrich, T. D.,
J. Laffin, and J. M. Lehman.
1994.
Induction of tetraploid DNA content by simian virus 40 is dependent on T-antigen function in the G2 phase of the cell cycle.
J. Virol.
68:4028-4030[Abstract/Free Full Text].
|
| 14.
|
Fry, A. M.,
T. Mayor, and E. A. Nigg.
2000.
Regulating centrosomes by protein phosphorylation.
Curr. Top. Dev. Biol.
49:291-312[Medline].
|
| 15.
|
Fry, A. M.,
P. Meraldi, and E. A. Nigg.
1998.
A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators.
EMBO J.
17:470-481[CrossRef][Medline].
|
| 16.
|
Glover, D. M.,
I. M. Hagan, and A. A. Tavares.
1998.
Polo-like kinases: a team that plays throughout mitosis.
Genes Dev.
12:3777-3787[Free Full Text].
|
| 17.
|
Harlow, E.,
L. V. Crawford,
D. C. Pim, and N. M. Williamson.
1981.
Monoclonal antibodies specific for simian virus 40 tumor antigens.
J. Virol.
39:861-869[Abstract/Free Full Text].
|
| 18.
|
Hiscott, J. B., and V. Defendi.
1981.
Simian virus 40 gene A regulation of cellular DNA synthesis. II. In nonpermissive cells.
J. Virol.
37:802-812[Abstract/Free Full Text].
|
| 19.
|
Howe, A. K.,
S. Gaillard,
J. S. Bennett, and K. Rundell.
1998.
Cell cycle progression in monkey cells expressing simian virus 40 small t antigen from adenovirus vectors.
J. Virol.
72:9637-9644[Abstract/Free Full Text].
|
| 20.
|
Hunt, T.,
F. C. Luca, and J. V. Ruderman.
1992.
The requirements for protein synthesis and degradation and the control of destruction of cyclins A and B in the meiotic and mitotic cell cycles of the clam embryo.
J. Cell Biol.
116:707-724[Abstract/Free Full Text].
|
| 21.
|
Li, Y.,
C. Gorbea,
D. Mahaffey,
M. Rechsteiner, and R. Benezra.
1997.
MAD2 associates with the cyclosome/anaphase-promoting complex and inhibits its activity.
Proc. Natl. Acad. Sci. USA.
94:12431-12436[Abstract/Free Full Text].
|
| 22.
|
Manfredi, J. J., and C. Prives.
1994.
The transforming activity of simian virus 40 large tumor antigen.
Biochim. Biophys. Acta
1198:65-83[Medline].
|
| 23.
|
Martin, R.,
V. Setlow,
C. Edwards, and D. Vembu.
1979.
The roles of the simian virus 40 tumor antigens in transformation of Chinese hamster lung cells.
Cell
17:635-643[CrossRef][Medline].
|
| 24.
|
Mayor, T.,
Y. D. Stierhof,
K. Tanaka,
A. M. Fry, and E. A. Nigg.
2000.
The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion.
J. Cell Biol.
151:837-846[Abstract/Free Full Text].
|
| 25.
|
Mungre, S.,
K. Enderle,
B. Turk,
A. Porras,
Y.-Q. Wu,
M. C. Mumby, and K. Rundell.
1994.
Mutations which affect the inhibition of protein phosphatase 2A by simian virus 40 small-t antigen in vitro decrease viral transformation.
J. Virol.
68:1675-1681[Abstract/Free Full Text].
|
| 26.
|
Okuda, M.,
H. F. Horn,
P. Tarapore,
Y. Tokuyama,
A. G. Smulian,
P.-K. Chan,
E. S. Knudsen,
I. A. Hofmann,
J. D. Snyder,
K. E. Bove, and K. Fukasawa.
2000.
Nucleophosmin/B23 is a target of cdk2/cyclin E in centrosome duplication.
Cell
103:127-140[CrossRef][Medline].
|
| 27.
|
Palazzo, R. E.,
J. M. Vogel,
B. J. Schnackenberg,
D. R. Hull, and X. Wu.
2000.
Centrosome maturation.
Curr. Top. Dev. Biol.
49:449-470[Medline].
|
| 28.
|
Pallas, D. C.,
L. K. Shahrik,
B. L. Martin,
S. Jaspers,
T. B. Miller,
D. L. Brautigan, and T. M. Roberts.
1990.
Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A.
Cell
60:167-176[CrossRef][Medline].
|
| 29.
|
Pallas, D. C.,
W. Weller,
S. Jaspers,
T. B. Miller,
W. S. Lane, and T. M. Roberts.
1992.
The third subunit of protein phosphatase 2A (PP2A), a 55-kilodalton protein which is apparently substituted for by T antigens in complexes with the 36- and 63-kilodalton PP2A subunits, bears little resemblance to T antigens.
J. Virol.
66:886-893[Abstract/Free Full Text].
|
| 30.
|
Paoletti, A.,
M. Moudjou,
M. Paintrand,
J. L. Salisbury, and M. Bornens.
1996.
Most of centrin in animal cells is not centrosome-associated and centrosomal centrin is confined to the distal lumen of centrioles.
J. Cell Sci.
109:3089-3102[Abstract].
|
| 31.
|
Passalaris, T. M.,
J. A. Benanti,
L. Gewin,
T. Kiyono, and D. A. Galloway.
1999.
The G2 checkpoint is maintained by redundant pathways.
Mol. Cell. Biol.
19:5872-5881[Abstract/Free Full Text].
|
| 32.
|
Pipas, J. M.
1992.
Common and unique features of T antigens encoded by the polyomavirus group.
J. Virol.
66:3979-3985[Abstract/Free Full Text].
|
| 33.
|
Porras, A.,
J. Bennett,
A. Howe,
K. Tokos,
N. Bouck,
B. Henglein,
S. Sathyamangalam,
B. Thimmapaya, and K. Rundell.
1996.
A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assays.
J. Virol.
70:6902-6908[Abstract/Free Full Text].
|
| 34.
|
Porras, A.,
S. Gaillard, and K. Rundell.
1999.
The simian virus 40 small-t and large-T antigens jointly regulate cell cycle reentry in human fibroblasts.
J. Virol.
73:3102-3107[Abstract/Free Full Text].
|
| 35.
|
Sanders, M. A., and J. L. Salisbury.
1994.
Centrin plays an essential role in microtubule severing during flagellar excision in Chlamydomonas reinhardtii.
J. Cell Biol.
124:795-805[Abstract/Free Full Text].
|
| 36.
|
Shtrichman, R.,
R. Sharf, and T. Kleinberger.
2000.
Adenovirus E4orf4 protein interacts with both Balpha and B' subunits of protein phosphatase 2A, but E4orf4-induced apoptosis is mediated only by the interaction with Balpha.
Oncogene
19:3757-3765[CrossRef][Medline].
|
| 37.
|
Snaith, H. A.,
C. G. Armstrong,
Y. Guo,
K. Kaiser, and P. T. Cohen.
1996.
Deficiency of protein phosphatase 2A uncouples the nuclear and centrosome cycles and prevents attachment of microtubules to the kinetochore in Drosophila microtubule star (mts) embryos.
J. Cell Sci.
109:3001-3012[Abstract].
|
| 38.
|
Sontag, E.,
S. Fedorov,
C. Kamibayashi,
D. Robbins,
M. Cobb, and M. Mumby.
1993.
The interaction of SV40 small t antigen with protein phosphatase 2A stimulates the Map kinase pathway and induces cell proliferation.
Cell
75:887-897[CrossRef][Medline].
|
| 39.
|
Sontag, E.,
V. Nunbhakdi-Craig,
G. Lee,
G. S. Bloom, and M. C. Mumby.
1996.
Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A.
Neuron
17:1201-1207[CrossRef][Medline].
|
| 40.
|
Srinivasan, A.,
A. J. McClellan,
J. Vartikar,
I. Marks,
P. Cantalupo,
Y. Li,
P. Whyte,
K. Rundell,
J. L. Brodsky, and J. M. Pipas.
1997.
The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain.
Mol. Cell. Biol.
17:4761-4773[Abstract].
|
| 41.
|
Stubdal, H.,
J. Zalvide,
K. S. Campbell,
C. Schweitzer,
T. M. Roberts, and J. A. DeCaprio.
1997.
Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen.
Mol. Cell. Biol.
17:4979-4990[Abstract].
|
| 42.
|
Thomas, J. T., and L. A. Laimins.
1998.
Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.
J. Virol.
72:1131-1137[Abstract/Free Full Text].
|
| 43.
|
Thompson, D. A.,
G. Belinsky,
T. H. Chang,
D. L. Jones,
R. Schlegel, and K. Munger.
1997.
The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints
Oncogene
15:3025-3035[CrossRef][Medline].
|
| 44.
|
Tooze, J.
1981.
Molecular biology of the tumor viruses, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 45.
|
Uto, K., and N. Sagata.
2000.
Nek2B, a novel maternal form of Nek2 kinase, is essential for the assembly or maintenance of centrosomes in early Xenopus embryos.
EMBO J.
19:1816-1826[CrossRef][Medline].
|
| 46.
|
Wahl, A. F.,
K. L. Donaldson,
C. Fairchild,
F. Y. Lee,
S. A. Foster,
G. W. Demers, and D. A. Galloway.
1996.
Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis.
Nat. Med.
2:72-79[CrossRef][Medline].
|
| 47.
|
Wang, Y., and D. J. Burke.
1997.
Cdc55p, the B-type regulatory subunit of protein phosphatase 2A, has multiple functions in mitosis and is required for the kinetochore/spindle checkpoint in Saccharomyces cerevisiae.
Mol. Cell. Biol.
17:620-626[Abstract].
|
| 48.
|
Yang, S.-I.,
R. L. Lickteig,
R. Estes,
K. Rundell,
G. Walter, and M. C. Mumby.
1991.
Control of protein phosphatase 2A by simian virus 40 small t antigen.
Mol. Cell. Biol.
11:1988-1995[Abstract/Free Full Text].
|
| 49.
|
Zalvide, J.,
H. Stubdal, and J. A. DeCaprio.
1998.
The J domain of simian virus 40 large T antigen is required to functionally inactivate RB family members.
Mol. Cell. Biol.
18:1408-1415[Abstract/Free Full Text].
|
| 50.
|
Zerrahn, J.,
U. Knippschild,
T. Winkler, and W. Deppert.
1993.
Independent expression of the transforming amino-terminal domain of large T antigen from an alternatively spliced third SV40 early mRNA
EMBO J.
12:4739-4746[Medline].
|
| 51.
|
Zhou, H.,
J. Kuang,
L. Zhong,
W. L. Kuo,
J. W. Gray,
A. Sahin,
B. R. Brinkley, and S. Sen.
1998.
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.
Nat. Genet.
20:189-193[CrossRef][Medline].
|
Journal of Virology, October 2001, p. 9799-9807, Vol. 75, No. 20
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.20.9799-9807.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chi, Y.-H., Haller, K., Ward, M. D., Semmes, O. J., Li, Y., Jeang, K.-T.
(2008). Requirements for Protein Phosphorylation and the Kinase Activity of Polo-like Kinase 1 (Plk1) for the Kinetochore Function of Mitotic Arrest Deficiency Protein 1 (Mad1). J. Biol. Chem.
283: 35834-35844
[Abstract]
[Full Text]
-
Gill, M. B., Kutok, J. L., Fingeroth, J. D.
(2007). Epstein-Barr Virus Thymidine Kinase Is a Centrosomal Resident Precisely Localized to the Periphery of Centrioles. J. Virol.
81: 6523-6535
[Abstract]
[Full Text]
-
Moreno, C. S., Ramachandran, S., Ashby, D. G., Laycock, N., Plattner, C. A., Chen, W., Hahn, W. C., Pallas, D. C.
(2004). Signaling and Transcriptional Changes Critical for Transformation of Human Cells by Simian Virus 40 Small Tumor Antigen or Protein Phosphatase 2A B56{gamma} Knockdown. Cancer Res.
64: 6978-6988
[Abstract]
[Full Text]
-
Chang, F., Re, F., Sebastian, S., Sazer, S., Luban, J.
(2004). HIV-1 Vpr Induces Defects in Mitosis, Cytokinesis, Nuclear Structure, and Centrosomes. Mol. Biol. Cell
15: 1793-1801
[Abstract]
[Full Text]
-
Yun, C., Cho, H., Kim, S.-J., Lee, J.-H., Park, S. Y., Chan, G. K., Cho, H.
(2004). Mitotic Aberration Coupled With Centrosome Amplification Is Induced by Hepatitis B Virus X Oncoprotein via the Ras-Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase-Mitogen-Activated Protein Pathway. Mol Cancer Res
2: 159-169
[Abstract]
[Full Text]
-
Garcea, R. L., Imperiale, M. J.
(2003). Simian Virus 40 Infection of Humans. J. Virol.
77: 5039-5045
[Full Text]
-
Nunbhakdi-Craig, V., Craig, L., Machleidt, T., Sontag, E.
(2003). Simian Virus 40 Small Tumor Antigen Induces Deregulation of the Actin Cytoskeleton and Tight Junctions in Kidney Epithelial Cells. J. Virol.
77: 2807-2818
[Abstract]
[Full Text]
-
Okubo, E., Lehman, J. M., Friedrich, T. D.
(2002). Negative Regulation of Mitotic Promoting Factor by the Checkpoint Kinase Chk1 in Simian Virus 40 Lytic Infection. J. Virol.
77: 1257-1267
[Abstract]
[Full Text]
-
Mauser, A., Holley-Guthrie, E., Simpson, D., Kaufmann, W., Kenney, S.
(2002). The Epstein-Barr Virus Immediate-Early Protein BZLF1 Induces both a G2 and a Mitotic Block. J. Virol.
76: 10030-10037
[Abstract]
[Full Text]